FCF Life Sciences
Venture Capital Report
The FCF Life Sciences Venture Capital Report is the most detailed and comprehensive analysis of venture capital funding activities of European biotechnology, pharmaceutical and medical technology companies. Categorized by subsectors / indications, it provides a detailed investigation on funding dynamics in Europe and the US.

FCF Life Sciences Venture Capital Report
Deal Analysis...
Fund Raising Analysis...
Cross-Border Analysis...
Sub-sector Analysis...
Investor Analysis...
and more...
Previous
Next

The following trends in 2020 were identified in Europe:

  • Financing volumes in the European Life Sciences sector have reached a new record high of approximately EUR 8.6bn in 2020 (an increase of +38% compared to 2019) while the number of deals have slightly decreased
  • UK continued to record the most transactions and highest volumes throughout the last 5 years
  • In 2020, the biotechnology sector leads with EUR 5.3bn, by far, in aggregated deal volumes, however, the medical technology sector has recorded the highest number of deals (465)
  • Oncology was again the most targeted indication within the biotechnology sector in 2020 (96 deals), followed by Infectious Diseases with 35 deals
  • With a financing volume of EUR 560m, CureVac is leading the top 10 European Life Sciences Deals in 2020
  • Cross-border investors tend to play a more important role, especially in later stage rounds, with the US being the most important cross-border investor in Europe
FCF Life Sciences Venture Capital Report
Deal Analysis...
Fund Raising Analysis...
Cross-Border Analysis...
Sub-sector Analysis...
Investor Analysis...
and more...
Previous
Next

RESEARCH

We constantly engage in capital markets research to identify financing trends early in the Life Sciences sector. Our research focuses on the most relevant equity markets: Venture Capital, Public Equity, Initial Public Offerings (IPO). The findings are currently published in the following publications:

Licensing

Recent licensing trends of European Biotech companies in China
Upcoming
Recent licensing trends of European Biotech companies in China
Upcoming

Biotech Licensing Monitor – China
-Upcoming-
Recent licensing trends of European Biotech companies in China

NEWS & PRESS

Scroll Up